Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Laura Fanning"'
Autor:
Adam Irving, Dennis Petrie, Anthony Harris, Laura Fanning, Erica M. Wood, Elizabeth Moore, Cameron Wellard, Neil Waters, Kim Huynh, Bradley Augustson, Gordon Cook, Francesca Gay, Georgia McCaughan, Peter Mollee, Andrew Spencer, Zoe K. McQuilten
Publikováno v:
PLoS ONE, Vol 19, Iss 8 (2024)
Externí odkaz:
https://doaj.org/article/ea88d2d26c874da39a7e37776973beb6
Autor:
Laura Fanning, Ekaterina Woods, Catherine J. Hornung, Kirsten P. Perrett, Mimi L.K. Tang, Kim Dalziel
Publikováno v:
Value in Health. 25:1460-1462
Autor:
Laura Fanning, Kirsten P Perrett, Catherine J. Hornung, Mimi L.K. Tang, Ekaterina Woods, Kim Dalziel
Publikováno v:
Value in Health. 24:1360-1376
Objectives To identify published economic evaluations of interventions aimed at preventing, diagnosing, or treating food allergies in children. Methods We examined economic evaluations published from 2000 to 2019. Data analyzed included: food allergy
Autor:
Timothy M, Miller, Merit E, Cudkowicz, Angela, Genge, Pamela J, Shaw, Gen, Sobue, Robert C, Bucelli, Adriano, Chiò, Philip, Van Damme, Albert C, Ludolph, Jonathan D, Glass, Jinsy A, Andrews, Suma, Babu, Michael, Benatar, Christopher J, McDermott, Thos, Cochrane, Sowmya, Chary, Sheena, Chew, Han, Zhu, Fan, Wu, Ivan, Nestorov, Danielle, Graham, Peng, Sun, Manjit, McNeill, Laura, Fanning, Toby A, Ferguson, Stephanie, Fradette, Cathy, Zhong
Publikováno v:
The New England journal of medicine. 387(12)
The intrathecally administered antisense oligonucleotide tofersen reduces synthesis of the superoxide dismutase 1 (SOD1) protein and is being studied in patients with amyotrophic lateral sclerosis (ALS) associated with mutations inIn this phase 3 tri
Autor:
Kevin McNamara, Cathy Ngo, Laura Fanning, Bill Suen, Stefanie Johnston, Peteris Darzins, Suzanne Mary Caliph, David A. Taylor, Gregory Duncan
Publikováno v:
Research in Social and Administrative Pharmacy. 17:460-465
Introduction A substantial proportion of hospital admissions and readmissions are directly attributable to preventable medication-related harm. Interventions that reduce these harms could avert significant suffering and healthcare costs. Objectives T
Autor:
Ian C. K. Wong, Laura Fanning, Wallis C.Y. Lau, Pajaree Mongkhon, Kenneth K.C. Man, Kirstie H. T. W. Wong
Publikováno v:
EP Europace. 23:39-48
Aims Comparative fracture risk for non-vitamin K antagonist oral anticoagulants (NOACs) and vitamin K antagonists (VKAs) among patients with atrial fibrillation (AF) remains unclear. This study aimed to provide summary relative risk (RR) estimates fo
Autor:
Laura Fanning, Wallis C.Y. Lau, Ian C. K. Wong, Peteris Darzins, Xue Li, Li Wei, Jenni Ilomäki, Pajaree Mongkhon, Esther W. Chan, Kenneth K.C. Man, Wai K. Leung, J. Simon Bell
Publikováno v:
Pharmacoepidemiology and Drug Safety. 29:1550-1561
Purpose Comparative gastrointestinal bleeding (GIB) risk between rivaroxaban and low-dose aspirin is unknown in patients with atrial fibrillation (AF). This study investigated GIB risk with rivaroxaban vs aspirin among two separate AF cohorts in Hong
Autor:
Chuenjid Kongkaew, Ian C. K. Wong, Laura Fanning, Wallis C.Y. Lau, Pajaree Mongkhon, Li Wei, Hassan Alwafi
Publikováno v:
British Journal of Clinical Pharmacology. 87:1056-1068
AIMS Oral anticoagulant (OAC) is recommended for preventing stroke in atrial fibrillation (AF). However, the OAC utilisation in AF patients with dementia or cognitive impairment (CI) is limited. This study aimed to examine the prevalence of OAC presc
Autor:
Robert C. Bucelli, Manjit McNeill, Shafeeq Ladha, Angela Genge, Stephanie Fradette, Ivan Nestorov, John Ravits, Philip Van Damme, Roger Lane, Christopher J McDermott, Jonathan Glass, Merit Cudkowicz, Laura Fanning, C. Frank Bennett, Heiko Runz, Ih Chang, Hani Houshyar, Toby A. Ferguson, Alfred Sandrock, Alan Pestronk, Danielle Graham, Timothy M. Miller, Randall G. Trudell, Nazem Atassi, Peter M. Andersen, François Salachas, Nicholas J. Maragakis, Albert L. Ludolph, Pamela J. Shaw, Lorne Zinman, Alexander McCampbell
Publikováno v:
New England Journal of Medicine. 383:109-119
Background Tofersen is an antisense oligonucleotide that mediates the degradation of superoxide dismutase 1 (SOD1) messenger RNA to reduce SOD1 protein synthesis. Intrathecal administratio...
Autor:
Michael Benatar, Joanne Wuu, Peter M. Andersen, Robert C. Bucelli, Jinsy A. Andrews, Markus Otto, Nita A. Farahany, Elizabeth A. Harrington, Weiping Chen, Adele A. Mitchell, Toby Ferguson, Sheena Chew, Liz Gedney, Sue Oakley, Jeong Heo, Sowmya Chary, Laura Fanning, Danielle Graham, Peng Sun, Yingying Liu, Janice Wong, Stephanie Fradette
Despite extensive research, amyotrophic lateral sclerosis (ALS) remains a progressive and invariably fatal neurodegenerative disease. Limited knowledge of the underlying causes of ALS has made it difficult to target upstream biological mechanisms of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2141520e84778c486c10046b7ad1a18c
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-200431
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-200431